Informazioni
Non ci sono recensioni
Punto di Riferimento
per Medici e Operatori Sanitari
per Medici e Operatori Sanitari
LIBRERIA STUDIUM
Medicines For Women
Harrison-Woolrych
Editore
Springer
Anno
2015
Pagine
627
ISBN
9783319124056
40,00 €
Description
n this definitive new text, the major medicines, devices and vaccines used by women worldwide are brought together for the first time in a single volume. Written and edited by international experts with an evidence-based approach, the book offers a comprehensive summary of all the key areas of women’s medicines. In the first part, issues relating to female drug exposure and considerations for prescribing for subgroups of women - for example during pregnancy and lactation - are presented in the context of contemporary clinical practice. In the second part, specific groups of pharmaceutical products are reviewed, including oral contraceptives, emergency contraception, treatment of chronic pelvic pain, hormone replacement therapy, bisphosphonates, herbal medicines for women, contraceptive devices and human papilloma virus (HPV) vaccines. Every chapter reviews and summarises the efficacy and safety of each group of products and concludes with a useful set of clinical take home messages. In the third part, broader perspectives are presented - from a primary care overview of prescribing for women, through to regulatory, political and religious aspects, including issues with women’s medicines in developing countries. The final two chapters focus on risk communication and conclude that women themselves should be placed at the centre of all discussions about their medicines.
The book is aimed at prescribers, other healthcare professionals and students in the field of women’s health throughout the world. It is an extremely valuable resource for all in clinical practice, for students of medicine, nursing, pharmacy and related sciences, and also for those in medicines regulation, pharmacovigilance and the pharmaceutical industry.
Table of Contents
Part I Prescribing Medicines for Women: General Principles
and Consideration of Special Sub-populations
1 Medicines for Women: Medicines for Half the World . . . . . . . . . . 3
Mira Harrison-Woolrych
2 Effects of Sex Differences in the Pharmacokinetics of Drugs
and Their Impact on the Safety of Medicines in Women . . . . . . . . 41
Emmanuel O. Fadiran and Lei Zhang
3 Prescribing Medicines to Adolescent Women . . . . . . . . . . . . . . . . . 69
Sue Bagshaw
4 Medication Use in Pregnancy; Treating the Mother: Protecting
the Unborn . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97
Yifat Gadot and Gideon Koren
Part II Specific Medicinal Products for Women: Benefits and Risks
5 Oral Contraceptives: Benefits and Risks . . . . . . . . . . . . . . . . . . . . . 141
Julie Craik and Louise Melvin
6 Oral Contraceptives and the Risk of Venous Thromboembolism . . . 181
Susan Jick
7 Emergency Contraception . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 203
Katarina Ilic
8 Contraceptive Devices for Women: Implants, Intrauterine Devices
and Other Products . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 227
Julie Craik and Sam Rowlands
9 Human Papilloma Virus Vaccines . . . . . . . . . . . . . . . . . . . . . . . . . . 271
Margaret Stanley
10 Medical Treatment of Chronic Pelvic Pain . . . . . . . . . . . . . . . . . . . 291
Wayne R. Gillett and David Jones
11 Menopausal Hormone Therapy: A Safety Perspective . . . . . . . . . . 331
Emily Banks
12 Bisphosphonates for Osteoporosis . . . . . . . . . . . . . . . . . . . . . . . . . . 345
Stuart Ralston
13 Herbal and Complementary Medicines Used for Women’s Health. . . 373
Sheila M. Wicks and Gail B. Mahady
Part III International Perspectives on Medicines for Women
and Risk Communication
14 A Primary Care Perspective on Prescribing for Women . . . . . . . . 403
Dee Mangin
15 A Medicines Regulatory Perspective on Women’s Medicines . . . . . 433
June M. Raine and Janet M. Nooney
16 Political and Religious Perspectives on Managing the Risks
and Benefits of Women’s Medicines . . . . . . . . . . . . . . . . . . . . . . . . 459
Brian Edwards and Veronika Valdova
17 Perspectives on Women’s Health and Medicines in Developing
Countries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 497
Nighat M. Khan
18 Perspectives on Risk Communication and Gender Issues . . . . . . . . 531
Bruce Hugman
19 Risk Communication and Specific Medicines for Women . . . . . . . . 585
Bruce Hugman
